Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 SAD and Food Effect of Rifasutenizol in Healthy Participants
NCT06081699Phase 1Completed
- Sponsor
- TenNor Therapeutics
- Start
- May 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of rifasutenizol in Helicobacter pylori infection (9 cohorts), sponsored by TenNor Therapeutics. Primary endpoint: Adverse Events. Started May 2019; status: completed.
02
Drugs
rifasutenizol
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06081699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06081699.